To exclude the possibility that the mAb may directly deliver a death signal into AML cells through cell-surface PD-1H, we also assessed in vivo growth of C1498 engineered to express PD-1H without its intracellular domain (C1498FF–PD-1H-Δ). Here, VSIR is linked to acute myeloid leukemia.